Amalgamated Bank Bio Techne Corp Transaction History

Amalgamated Bank

  • $11.7 Billion
  • Q1 2025

A detailed history of Amalgamated Bank transactions in Bio Techne Corp stock. As of the latest transaction made, Amalgamated Bank holds 30,646 shares of TECH stock, worth $1.51 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,646
Previous 30,424 0.73%
Holding current value
$1.51 Million
Previous $2.19 Million 17.98%
% of portfolio
0.02%
Previous 0.02%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025
BUY
$58.47 - $78.75 $12,980 - $17,482
222 Added 0.73%
30,646 $1.8 Million
Q4 2024

Feb 04, 2025
SELL
$66.37 - $78.17 $30,131 - $35,489
-454 Reduced 1.47%
30,424 $2.19 Million
Q3 2024

Oct 30, 2024
SELL
$70.96 - $82.35 $75,714 - $87,867
-1,067 Reduced 3.34%
30,878 $2.47 Million
Q2 2024

Aug 12, 2024
SELL
$62.12 - $84.15 $148,839 - $201,623
-2,396 Reduced 6.98%
31,945 $2.29 Million
Q1 2024

Apr 23, 2024
SELL
$65.98 - $77.09 $1.4 Million - $1.64 Million
-21,214 Reduced 38.19%
34,341 $2.42 Million
Q4 2023

Feb 06, 2024
SELL
$52.83 - $78.22 $85,584 - $126,716
-1,620 Reduced 2.83%
55,555 $4.29 Million
Q3 2023

Nov 08, 2023
SELL
$67.52 - $89.42 $63,536 - $84,144
-941 Reduced 1.62%
57,175 $3.89 Million
Q2 2023

Aug 11, 2023
BUY
$73.76 - $85.98 $41,526 - $48,406
563 Added 0.98%
58,116 $4.74 Million
Q1 2023

May 02, 2023
SELL
$71.62 - $86.62 $228,109 - $275,884
-3,185 Reduced 5.24%
57,553 $4.27 Million
Q4 2022

Feb 10, 2023
BUY
$80.67 - $352.29 $3.7 Million - $16.1 Million
45,813 Added 306.95%
60,738 $5.03 Million
Q3 2022

Nov 09, 2022
BUY
$282.54 - $391.85 $14,974 - $20,768
53 Added 0.36%
14,925 $4.24 Million
Q2 2022

Aug 15, 2022
SELL
$322.67 - $449.65 $215,543 - $300,366
-668 Reduced 4.3%
14,872 $5.16 Million
Q1 2022

Jun 30, 2022
BUY
$353.85 - $487.79 $100,139 - $138,044
283 Added 1.85%
15,540 $6.73 Million
Q4 2021

Feb 15, 2022
BUY
$456.15 - $525.06 $585,696 - $674,177
1,284 Added 9.19%
15,257 $7.89 Million
Q3 2021

Oct 29, 2021
SELL
$444.87 - $538.88 $7.65 Million - $9.26 Million
-17,187 Reduced 55.16%
13,973 $6.77 Million
Q2 2021

Aug 16, 2021
BUY
$387.35 - $450.26 $9.24 Million - $10.7 Million
23,866 Added 327.2%
31,160 $14 Million
Q1 2021

May 13, 2021
SELL
$314.62 - $411.0 $173,355 - $226,461
-551 Reduced 7.02%
7,294 $2.79 Million
Q4 2020

Feb 12, 2021
BUY
$246.9 - $321.87 $7,160 - $9,334
29 Added 0.37%
7,845 $2.49 Million
Q3 2020

Oct 30, 2020
SELL
$232.22 - $282.96 $48,069 - $58,572
-207 Reduced 2.58%
7,816 $1.94 Million
Q2 2020

Aug 10, 2020
SELL
$185.43 - $279.56 $411,840 - $620,902
-2,221 Reduced 21.68%
8,023 $2.12 Million
Q1 2020

May 13, 2020
SELL
$161.17 - $221.51 $25,142 - $34,555
-156 Reduced 1.5%
10,244 $1.94 Million
Q4 2019

Feb 13, 2020
BUY
$189.68 - $222.09 $103,944 - $121,705
548 Added 5.56%
10,400 $2.28 Million
Q3 2019

Nov 13, 2019
BUY
$183.56 - $216.72 $221,373 - $261,364
1,206 Added 13.95%
9,852 $1.93 Million
Q2 2019

Aug 14, 2019
SELL
$188.72 - $215.43 $34,347 - $39,208
-182 Reduced 2.06%
8,646 $1.8 Million
Q1 2019

May 15, 2019
BUY
$136.09 - $200.44 $16,602 - $24,453
122 Added 1.4%
8,828 $1.75 Million
Q4 2018

Feb 15, 2019
BUY
$132.75 - $203.8 $427,189 - $655,828
3,218 Added 58.64%
8,706 $1.26 Million
Q3 2018

Nov 14, 2018
SELL
$147.44 - $204.11 $528,424 - $731,530
-3,584 Reduced 39.51%
5,488 $1.12 Million
Q2 2018

Jul 18, 2018
BUY
$144.9 - $165.58 $114,760 - $131,139
792 Added 9.57%
9,072 $1.34 Million
Q1 2018

May 22, 2018
BUY
$131.46 - $151.04 $66,781 - $76,728
508 Added 6.54%
8,280 $1.25 Million
Q4 2017

Feb 13, 2018
BUY
$121.17 - $134.75 $48,346 - $53,765
399 Added 5.41%
7,772 $1.01 Million
Q3 2017

Nov 09, 2017
BUY
$113.59 - $123.78 $837,499 - $912,629
7,373
7,373 $891,000

Others Institutions Holding TECH

# of Institutions
627
Shares Held
160M
Call Options Held
90K
Put Options Held
14.2K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $1.93B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email